Clinical trial • Phase III • Oncology
JNJ-90301900 for Locally advanced head and neck squamous cell carcinoma
Phase III trial of JNJ-90301900 for Locally advanced head and neck squamous cell carcinoma. None/Not specified-controlled. 22 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Locally advanced head and neck squamous cell carcinoma
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 15-10-2025
- First CTIS Authorization Date
- 02-02-2026
Trial design
None/Not specified-controlled Phase III trial in France.
- Comparator
- None/Not specified
- Target Sample Size
- 22
Recruitment
- Planned Sample Size
- 22
- Recruitment Window Months
- 28
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 22
France
- Earliest CTIS Part Ii Submission Date
- 28-01-2026
- Latest Decision Or Authorization Date
- 02-02-2026
- Processing Time Days
- 5
- Number Of Sites
- 5
- Number Of Participants
- 8
Sites
- Site Name
- Centre Henri Becquerel
- Department Name
- Radiotherapy
- Principal Investigator Name
- Sébastien THUREAU
- Principal Investigator Email
- sebastien.thureau@chb.unicancer.fr
- Contact Person Name
- Sébastien THUREAU
- Contact Person Email
- sebastien.thureau@chb.unicancer.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- Radiotherapy
- Principal Investigator Name
- France Thanh-Van NGUYEN
- Principal Investigator Email
- th.nguyen@gustaveroussy.fr
- Contact Person Name
- France Thanh-Van NGUYEN
- Contact Person Email
- th.nguyen@gustaveroussy.fr
- Site Name
- Centre Hospitalier Regional Et Universitaire De Brest
- Department Name
- Radiotherapy
- Principal Investigator Name
- Ulrike SCHICK
- Principal Investigator Email
- ulrike.schick@chu-brest.fr
- Contact Person Name
- Ulrike SCHICK
- Contact Person Email
- ulrike.schick@chu-brest.fr
- Site Name
- Centre Hospitalier Regional De Marseille
- Department Name
- Centre d’Essais Précoces en Cancérologie de Marseille
- Principal Investigator Name
- Sébastien SALAS
- Principal Investigator Email
- Sebastien.SALAS@ap-hm.fr
- Contact Person Name
- Sébastien SALAS
- Contact Person Email
- Sebastien.SALAS@ap-hm.fr
- Site Name
- Centre Oscar Lambret
- Department Name
- Radiotherapy
- Principal Investigator Name
- Xavier LIEM
- Principal Investigator Email
- x-liem@o-lambret.fr
- Contact Person Name
- Xavier LIEM
- Contact Person Email
- x-liem@o-lambret.fr
Sponsor
Primary sponsor
- Full Name
- Janssen Cilag International
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Belgium
Investigational products
- Investigational Product Name
- JNJ-90301900
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.
- EZABENLIMAB for Locally advanced head and neck squamous cell carcinoma
- HAFNIUM OXIDE for Locally advanced head and neck squamous cell carcinoma
- Lenvatinib for Locally advanced head and neck squamous cell carcinoma
- PUCOTENLIMAB for Locally advanced head and neck squamous cell carcinoma
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer